https://www.avient.com/sites/default/files/2024-02/AVNT Q4 2023 Earnings Press Release.pdf
Rose
Vice President, Marketing and Communications
Avient Corporation
+1 440-930-3162
kyle.rose@avient.com
mailto:giuseppe.disalvo@avient.com
mailto:kyle.rose@avient.com
6
Attachment 1
Avient Corporation
Summary of Condensed Consolidated Statements of Income (Unaudited)
(In millions, except per share data)
Three Months Ended
December 31,
Year Ended
December 31,
2023 2022 2023 2022
Sales $ 719.0 $ 790.4 $ 3,142.8 $ 3,396.9
Operating income 43.1 0.4 196.8 243.3
Net income (loss) from continuing operations attributable to Avient
shareholders 27.8 (17.0) 75.8 82.8
Diluted earnings (loss) per share from continuing operations attributable
$ 0.30 $ (0.19) $ 0.83 $ 0.90
Senior management uses comparisons of adjusted net income from continuing operations attributable to Avient shareholders
and diluted adjusted earnings per share (EPS) from continuing operations attributable to Avient shareholders, excluding special
items, to assess performance and facilitate comparability of results.
Three Months Ended
December 31,
2023 2022
Reconciliation to Condensed Consolidated Statements of Income $ EPS(1) $ EPS(1)
Net income (loss) from continuing operations attributable to Avient
shareholders $ 27.8 $ 0.30 $ (17.0) $ (0.19)
Special items, after tax (Attachment 3) 5.4 0.06 38.3 0.42
Amortization expense, after-tax 15.0 0.16 14.6 0.16
Adjusted net income / EPS $ 48.2 $ 0.52 $ 35.9 $ 0.39
(1) Per share amounts may not recalculate from figures presented herein due to rounding
Year Ended
December 31,
2023 2022
Reconciliation to Condensed Consolidated Statements of Income $ EPS(1) $ EPS(1)
Net income from continuing operations attributable to Avient shareholders $ 75.8 $ 0.83 $ 82.8 $ 0.90
Special items, after tax (Attachment 3) 79.3 0.86 116.2 1.26
Amortization expense, after-tax 61.5 0.67 49.0 0.53
Adjusted net income / EPS $ 216.6 $ 2.36 $ 248.0 $ 2.69
(1) Per share amounts may not recalculate from figures presented herein due to rounding
7
Attachment 2
Avient Corporation
Condensed Consolidated Statements of Income (Unaudited)
(In millions, except per share data)
Three Months Ended
December 31,
Year Ended
December 31,
2023 2022 2023 2022
Sales $ 719.0 $ 790.4 $ 3,142.8 $ 3,396.9
Cost of sales 510.1 618.4 2,250.3 2,514.2
Gross margin 208.9 172.0 892.5 882.7
Selling and administrative expense 165.8 171.6 695.7 639.4
Operating income 43.1 0.4 196.8 243.3
Interest expense, net (26.8) (49.4) (115.3) (119.8)
Other income (expense), net 4.3 (28.4) 5.8 (59.7)
Income (loss) from continuing operations before income taxes 20.6 (77.4) 87.3 63.8
Income tax benefit (expense) 7.0 60.8 (11.0) 19.3
Net income (loss) from continuing operations 27.6 (16.6) 76.3 83.1
Income (loss) from discontinued operations, net of income taxes 0.8 561.5 (0.1) 620.3
Net income 28.4 544.9 76.2 703.4
Net loss (income) attributable to noncontrolling interests 0.2 (0.4) (0.5) (0.3)
Net income attributable to Avient common shareholders $ 28.6 $ 544.5 $ 75.7 $ 703.1
Earnings (loss) per share attributable to Avient common shareholders - Basic:
Continuing operations $ 0.30 $ (0.19) $ 0.83 $ 0.91
Discontinued operations 0.01 6.17 — 6.80
Total $ 0.31 $ 5.98 $ 0.83 $ 7.71
Earnings (loss) per share attributable to Avient common shareholders - Diluted:
Continuing operations $ 0.30 $ (0.19) $ 0.83 $ 0.90
Discontinued operations 0.01 6.17 — 6.73
Total $ 0.31 $ 5.98 $ 0.83 $ 7.63
Cash dividends declared per share of common stock $ 0.2575 $ 0.2475 $ 1.0000 $ 0.9600
Weighted-average shares used to compute earnings per common share:
Basic 91.2 91.0 91.1 91.2
Diluted 91.9 91.0 91.8 92.2
8
Attachment 3
Avient Corporation
Summary of Special Items (Unaudited)
(In millions, except per share data)
Special items (1)
Three Months Ended
December 31,
Year Ended
December 31,
2023 2022 2023 2022
Cost of sales:
Restructuring costs, including accelerated depreciation $ (2.0) $ (21.3) $ (11.9) $ (31.1)
Environmental remediation costs (17.2) (0.4) (69.7) (24.2)
Reimbursement of previously incurred environmental costs 1.6 — 1.6 8.3
Acquisition related costs — (23.8) — (34.1)
Impact on cost of sales (17.6) (45.5) (80.0) (81.1)
Selling and administrative expense:
Restructuring and employee separation costs (1.1) (4.3) (14.9) (5.3)
Legal and other (6.1) (4.0) (15.2) (3.0)
Acquisition related costs (1.3) (6.1) (5.9) (19.3)
Impact on selling and administrative expense (8.5) (14.4) (36.0) (27.6)
Impact on operating income (26.1) (59.9) (116.0) (108.7)
Interest expense, net - financing costs (0.1) (16.0) (2.3) (26.0)
Mark-to-market on derivatives — — — (30.9)
Pension and post retirement mark-to-market adjustment and other 3.8 (28.4) 3.7 (28.4)
Impact on other income (expense), net 3.8 (28.4) 3.7 (59.3)
Impact on income from continuing operations before income taxes (22.4) (104.3) (114.6) (194.0)
Income tax benefit on above special items 4.5 26.8 27.7 49.4
Tax adjustments(2) 12.5 39.2 7.6 28.4
Impact of special items on net income from continuing operations $ (5.4) $ (38.3) $ (79.3) $ (116.2)
Diluted earnings per common share impact $ (0.06) $ (0.42) $ (0.86) $ (1.26)
Weighted average shares used to compute adjusted earnings per share:
Diluted 91.9 91.7 91.8 92.2
(1) Special items include charges related to specific strategic initiatives or financial restructuring such as: consolidation of operations; debt
extinguishment costs; costs incurred directly in relation to acquisitions or divestitures; employee separation costs resulting from personnel
reduction programs, plant realignment costs, executive separation agreements; asset impairments; settlement gains or losses and mark-to-
market adjustments associated with gains and losses on pension and other post-retirement benefit plans; environmental remediation costs,
fines, penalties and related insurance recoveries related to facilities no longer owned or closed in prior years; gains and losses on the
divestiture of operating businesses, gains and losses on facility or property sales or disposals; results of litigation, fines or penalties, where
such litigation (or action relating to the fines or penalties) arose prior to the commencement of the performance period; one-time, non-
recurring items; and the effect of changes in accounting principles or other such laws or provisions affecting reported results
Three Months Ended
December 31,
Year Ended
December 31,
2023 2022 2023 2022
Sales:
Color, Additives and Inks $ 459.4 $ 490.8 $ 2,007.4 $ 2,355.0
Specialty Engineered Materials 259.8 300.8 1,138.2 1,044.4
Corporate (0.2) (1.2) (2.8) (2.5)
Sales $ 719.0 $ 790.4 $ 3,142.8 $ 3,396.9
Gross margin:
Color, Additives and Inks $ 148.3 $ 134.5 $ 631.2 $ 681.3
Specialty Engineered Materials 78.1 82.4 341.8 283.7
Corporate (17.5) (44.9) (80.5) (82.3)
Gross margin $ 208.9 $ 172.0 $ 892.5 $ 882.7
Selling and administrative expense:
Color, Additives and Inks $ 86.5 $ 90.2 $ 371.3 $ 380.3
Specialty Engineered Materials 48.7 47.2 199.3 143.6
Corporate 30.6 34.2 125.1 115.5
Selling and administrative expense $ 165.8 $ 171.6 $ 695.7 $ 639.4
Operating income:
Color, Additives and Inks $ 61.8 $ 44.3 $ 259.9 $ 301.0
Specialty Engineered Materials 29.4 35.2 142.5 140.1
Corporate (48.1) (79.1) (205.6) (197.8)
Operating income $ 43.1 $ 0.4 $ 196.8 $ 243.3
13
Attachment 7
Avient Corporation
Reconciliation of Non-GAAP Financial Measures (Unaudited)
(In millions, except per share data)
Senior management uses gross margin before special items and operating income before special items to assess performance
and allocate resources because senior management believes that these measures are useful in understanding current
profitability levels and how it may serve as a basis for future performance.
https://www.avient.com/sites/default/files/2023-03/Trilliant HC glass-filled PK - Biopharma Tubing Clamps.pdf
BIOPHARMACEUTICAL
SUPPLY COMPANY
T U B I N G C L A M P
• High impact and wear resistance
• Low moisture uptake
• Comparable dimensional stability to nylon
• Eco-conscious alternative to PA66 and PA6
• Delivered a comparable alternative to nylons
during supply shortages, resulting in rugged
performance and a lower carbon footprint
• Provided improved chemical resistance to
nylon clamps to withstand repeated cleanings
from harsh disinfectants
• Offered a global manufacturing footprint to
support future expansion of the end products
to markets outside the Americas
Trilliant™ HC 8910 Glass-Filled Polyketone
Thermoplastics
KEY REQUIREMENTS
WHY AVIENT
AVIENT SOLUTION
DURABILITY + MATERIAL AVAILABILITY
LEARN MORE
Copyright © 2023, Avient Corporation.
https://www.avient.com/products/engineered-polymer-formulations/chemical-corrosion-resistant-formulations/trilliant-hc-healthcare-thermoplastics